why novartis� landmark cancer drug approval is great news for bluebird
.
. boston cio of the year® orbie® awards
.
.
the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.� . .
executive director of saen michael budkie made these reports public in a letter addressed to chancellor carol christ on wednesday .
"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust.
.